R. Alta Charo, JD, is the Warren P. Knowles Professor of Law & Bioethics, University of Wisconsin Law School and School of Medicine & Public Health. She teaches a variety of courses covering bioethics, public health law, biotechnology policy, and torts. Her government positions have included work as a Senior Advisor in the Office of the Commissioner at FDA; Policy Analyst for the US Agency for International Development; and Legal Analyst for the Congressional Office of Technology Assessment.
Rebecca Dresser, JD, is the Daniel Noyes Kirby Professor of Law and Professor of Ethics in Medicine at Washington University in St. Louis. Since 1983, she has taught medical and law students about legal and ethical issues in end-of-life care, biomedical research, genetics, assisted reproduction, and related topics. Before coming to Washington University, she taught at Baylor College of Medicine and Case Western Reserve University. In 2003, she was a Visiting Research Scholar at the University of Tokyo, where she taught a short course in law and bioethics. She is a Fellow of the Hastings Center and is one of the "At Law" columnists for the Hastings Center Report. Dresser has written commissioned papers for the National Academy of Sciences and National Bioethics Advisory Commission. From 2002-2009, she was a member of the President's Council on Bioethics.
Arthur G. Erdman, PhD, is the Richard C. Jordan Professor and a Morse Alumni Distinguished Teaching Professor of Mechanical Engineering, University of Minnesota. Prof. Erdman specializes in mechanical design, bioengineering and product design. He has published over 325 technical papers, 3 books, holds over 30 patents, and shares with his former students 9 Best Paper Awards at international conferences.
Michael Etheridge, MSME & MS candidate, is Research Assistant, University of Minnesota. His current research focuses include improved predictive modeling for magnetic nanoparticle based hyperthermia and cryosurgical treatments of cancer.
Leili Fatehi, JD, is an Adjunct Associate Professor of Law at the University of Minnesota Law School. She received her JD from the University of Minnesota in 2010 and her BS from Cornell University in 2005. While in law school, Ms. Fatehi was Editor-in-Chief of the Minnesota Journal of Law, Science & Technology. Ms. Fatehi's research interests are in legal, economic, and societal implications of environmental and health regulation of emerging technologies and the relationship between administration law and technology more generally.
Ralph F. Hall, JD, is Distinguished Professor and Practitioner of Law, University of Minnesota, and Counsel to the Indianapolis, Indiana law firm of Baker & Daniels. He counsels clients in the area of drug and medical device regulation. He also serves as CEO of MR3 Medical LLC, a start-up medical device company. He is a Co-Investigator on the Consortium's NIH/NHGRI grant on "Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight" (Award # 1-RC1-HG005338-01).
Christy Haynes, PhD, is a McKnight Land-Grant Assistant Professor, Chemistry, University of Minnesota. Her research focuses on fundamental and applied problems in immunology, nanoscience, and environmental science using a diverse set of techniques, with applications ranging from drug delivery to environmental sensors. She combines knowledge of nanoparticles and biological cells to investigate the potential cytotoxicity of nanoparticles in consumer products.
Robert Hoerr, MD, PhD, is the Co-Founder and Director, Nanocopoeia, Inc. Nanocopoeia is a Minnesota-based nanotechnology start-up, a drug formulation company bringing a proprietary ElectroNanoSpray™ technology for producing nanoparticles to the pharmaceutical and medical device industries.
John Howard, MD, MPH, JD, LLM is Director of the National Institute for Occupational Safety and Health in the U.S. Department of Health and Human Services. Dr. Howard also serves as the Administrator of the World Trade Center Health Program. Prior to his appointment as Director of NIOSH in 2002, Dr. Howard served as Chief of the Division of Occupational Safety and Health in the California Labor and Workforce Development Agency from 1991 through 2002. He has written numerous articles on occupational health law and policy.
Cortney Jones, JD, is Research Associate, Consortium on Law and Values in Health, Environment & the Life Sciences, University of Minnesota.
Jeffrey P. Kahn, PhD, MPH, is Director of the Center for Bioethics and Maas Family Chair in Bioethics; Professor, Department of Medicine, University of Minnesota Medical School; Division of health Services Research and Policy, School of Public Health; Department of Philosophy, University of Minnesota. Dr. Kahn works in a variety of areas of bioethics, exploring the intersection of ethics and public health policy, including research ethics, ethics and genetics, and ethical issues in public health. He has served on numerous state and federal advisory panels including the National Institutes of Health (NIH) Recombinant DNA Advisory Committee (RAC). He is a Co-Investigator on the Consortium's NIH/NHGRI grant on "Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight" (Award # 1-RC1-HG005338-01).
Moira Keane, MA, CIP, is Director of the Research Subjects' Protection Programs (RSPP) which includes the Institutional Review Board (IRB), the Institutional Animal Care and Use Committee (IACUC), and the Institutional Biosafety Committee (IBC), University of Minnesota. She is actively involved in subjects' protections and serves as Co-Chair of the Association for Accreditation of Human Research Programs (AAHRPP) Council on Accreditation. She serves as Vice Chair of the Council on Certified IRB Professionals (CCIP), is a member of the Secretary's Advisory Committee on Human Subjects Protection (SACHRP) Subpart A Sub Committee, and on the Board of Public Responsibility in Medicine and Research (PRIM&R).
George Khushf, PhD, is an Associate Professor in the Department of Philosophy at the University of South Carolina. He has written extensively on medical ethics and served as the managing editor of the Journal of Medicine and Philosophy. He is also the Humanities Director at the Center for Bioethics at USC. His current research focuses on moral philosophy and general bioethics, organizational ethics, philosophy of medicine, theological dimensions of ethics, and ethics of nanotechnology.
Jonathan Kimmelman, PhD, is Associate Professor, Biomedical Ethics Unit, Social Studies of Medicine, with cross appointments in Experimental Medicine and Human Genetics, McGill University. His research revolves around the ethical, social and policy dimensions of testing novel medical interventions in human beings for the first time. In 2006, he received the Institute of Genetics Maud Menten New Investigator Prize and currently holds a CIHR New Investigator Award. Kimmelman chaired the ethics committee of the American Society of Gene and Cell Therapy, 2008-2010, and sits on the ethics committee of the International Society of Stem Cell Research. He also serves on the CIHR Stem Cell Oversight Committee, as well as the Gene and Cell Therapy DSMB of U.S. National Heart, Lung, and Blood Institute.
Nancy M.P. King, JD, is Professor, Department of Social Sciences & Health Policy, Division of Public Health Sciences, Wake Forest University. Professor King joined the SSHP faculty in 2007, after nearly 20 years on the faculty of the School of Medicine, UNC-Chapel Hill. She has written and taught extensively on issues related to informed consent in health care and research, medical decisions at the beginning and end of life, the development and use of experimental technologies, and international and cross-cultural questions in human subjects research. In 2002 she was elected a Fellow of the Hastings Center. Professor King directs WFU's Research Ethics Consultation Program and serves on the School of Medicine's SIRE Committee and the iDSMB. She has cross-appointments in the Department of Internal Medicine, the Wake Forest Institute for Regenerative Medicine, and the Translational Science Institute.
Efrosini Kokkoli, PhD, is Associate Professor in the Department of Chemical Engineering & Materials Science, University of Minnesota. Prof. Kokkoli's research focuses on engineering peptide-amphiphiles and designing nanostructured interfaces that can specifically target adhesion molecules in pathological areas of interest with a subsequent release of the load (peptides, proteins, or genes) to the nucleus of the cell.
Frances Lawrenz, PhD, is Professor of Educational Psychology and Associate Vice President for Research, University of Minnesota. Her major research focus is science and mathematics program evaluation. Prof. Lawrenz is currently working on evaluation of several national science and mathematics programs. She is also interested in instrument development and in distinguishing among various types of assessments those that are most appropriate for a given situation.
Warren Lux, MD, is Director, Program in Human Research Ethics, U.S. Environmental Protection Agency (EPA) and an Affiliated Scholar, Georgetown University Center for Clinical Bioethics. He is a neurologist whose clinical focus has been on the treatment of persons with cognitive and behavioral disorders due to brain trauma and frontal lobe disease, and his research has utilized clinical neuroscience to inform philosophical understandings of personal autonomy. He has served on the neurology faculties at New York University, Georgetown University, and Washington University in St. Louis.
Gary Marchant, JD, MPP, PhD, is Professor of Law; Executive Director and Faculty Fellow; Center for Law, Science & Innovation; Lincoln Professor of Emerging Technologies, Law and Ethics; Senior Sustainability Scientist, Global Institute of Sustainability; and Associate Director, Origins Initiative, Arizona State University. His research interests include the use of genetic information in environmental regulation, risk and the precautionary principle, legal aspects of personalized medicine, and regulation of emerging technologies such as nanotechnology, neuroscience and biotechnology.
Andrew Maynard, PhD, is Director, Risk Science Center; Charles and Rita Gelman Risk Science Professor; and Professor of Environmental Health Sciences, University of Michigan School of Public Health. Prof. Maynard is a leading authority on the responsible development and use of emerging technologies. His research interests span identifying, assessing and managing emergent risks, to exploring innovative solutions to established and emerging human health and environmental risks, to equipping people with the tools they need to make informed decisions in the face of risk and uncertainty.
J. Jeffrey McCullough, MD, is Professor of Lab Medicine and Pathology; and Director, Institute of Engineering in Medicine, University of Minnesota. He is a Co-Investigator for the Consortium's NIH/NHGRI grant on "Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight" (Award # 1-RC1-HG005338-01).
Jerry Menikoff, MD, JD, MPP, is Director, Office for Human Research Protections (OHRP), U.S. Department of Health & Human Services. Prior to his current role, he was in charge of the human subjects protections program at the National Institutes of Health (NIH). Dr. Menikoff was also Associate Professor of Law, Ethics & Medicine at the University of Kansas School of Medicine. He has been a Faculty Fellow at the MacLean Center for Clinical Medical Ethics at the University of Chicago, and at the Center for Ethics and the Professions at Harvard University.
Gurumurthy Ramachandran, PhD, is Professor, Environmental Health Sciences, University of Minnesota. His research interests include retrospective exposure assessment; measurement of air pollution; statistical methods for analysis of exposure measurements; theoretical and experimental studies on the design of aerosol samplers; optical remote sensing applications in industrial hygiene; and indoor air quality. He is a Co-Investigator for the Consortium's NIH/NHGRI grant on "Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight" (Award # 1-RC1-HG005338-01).
David B. Resnik, PhD, JD, is a Bioethicist at the National Institute of Environmental Health Sciences. Dr. Resnik was an Associate and Full Professor of Medical Humanities at the Brody School of Medicine at East Carolina University (ECU) from 1998-2004, and an Associate Director of the Bioethics Center at ECU and University Health Systems from 1998-2004. He was Assistant and Associate Professor of Philosophy at the University of Wyoming (UW) from 1990-1998, and Director of the Center for the Advancement of Ethics at UW from 1995-1998. Dr. Resnik has published over 150 articles on various topics in philosophy and bioethics and is the author of 7 books. He serves on several editorial boards and is an Associate Editor of the journal Accountability in Research. Dr. Resnik is also Chair of the NIEHS Institutional Review Board.
Mihail Roco, PhD, is Senior Advisor for Nanotechnology at the National Science Foundation (NSF); Founding Chair of the U.S. National Science and Technology Council Subcommittee on Nanoscale Science, Engineering and Technology (NSET); and Managing Editor of the Journal of Nanoparticle Research. He also coordinates NSF's Grant Opportunities for Liaison with Industry program. Previously he was Professor of Mechanical Engineering at the University of Kentucky (1981-1995), and held visiting professorships at the California Institute of Technology (1988-89), Johns Hopkins University (1993-95), Tohoku University (1989), and Delft University of Technology (1997-98). He received the National Materials Advancement Award from the Federation of Materials Societies at the National Press Club in 2007 for NNI leadership.
Jeffery A. Schloss, PhD, is Program Director for Technology Development Coordination, Division of Extramural Research at the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). At NHGRI, he manages a grants program in technology development for DNA sequencing and single nucleotide polymorphism (SNP) scoring, and serves the NHGRI Division of Extramural Research and Office of the Director as a resource on genome technology development issues. He led the team that launched the Centers of Excellence in Genomic Science, and initiated a program to foster effective collaborations to validate new sequencing technologies for use in high-throughput laboratories. Dr. Schloss' program at the National Human Genome Research Institute centers on development of novel DNA sequencing technologies. He co-chairs the Nanomedicine Roadmap initiative, served as co-chair of the NIH Nano Task Force and is one of the NIH representatives to the federal working group for the National Nanotechnology Initiative. He was a founding member and chair of the NIH Bioengineering Consortium (BECON).
Ronald Siegel, ScD, is Professor, Department of Pharmaceutics, University of Minnesota. Professor Siegel's research interests lie in drug delivery systems, focusing on novel methods for achieving spatiotemporal control of drug release.
Samuel A. Wickline, MD, is Professor of Medicine, Physics, Biomedical Engineering, Cell Biology and Physiology, Director, Washington University Consortium for Translational Research in Advanced Imaging and Nanomedicine (C-TRAIN), Director, Siteman Center For Cancer Nanotechnology Excellence, Executive Faculty, Institute of Biological and Medical Engineering, and Co-Director, Cardiovascular Engineering Graduate Training Program, Biomedical Engineering Department, Washington University School of Medicine.
Susan M. Wolf, JD, is McKnight Presidential Professor of Law, Medicine & Public Policy, Faegre & Benson Professor of Law, Professor of Medicine, and Faculty Member, Center for Bioethics, University of Minnesota. She is also Chair of the University's Consortium on Law and Values in Health, Environment & the Life Sciences. Professor Wolf is an elected member of the National Academy of Sciences' Institute of Medicine (IOM), an elected fellow of the American Association for the Advancement of Science (AAAS), and an elected fellow of The Hastings Center as well as a past-member of the Fellows' Council. She has received numerous grants to support her research, including from the National Institutes of Health (NIH), National Science Foundation (NSF), and The Greenwall Foundation. Prof. Wolf is the Principal Investigator for the Consortium's NIH/NHGRI grant on "Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight" (Award # 1-RC1-HG005338-01).